IMMUNOSUPPRESSIVE THERAPY AFTER LIVER TRANSPLANTATION AND PREVENTION OF REJECTION SYNDROME
Keywords:
Liver transplantation (LT), Asian Liver Transplant Network (ALTN), Living donor liver transplantation (LDLT), Deceased donor liver transplantation (DDLT), Hepatocellular carcinoma (HCC), Hepatitis B virus (HBV), Hepatitis C virus (HCV), ImmunosuppressionAbstract
Background: Liver transplantation (LT) is a life-saving procedure for patients with end-stage liver disease and hepatocellular carcinoma. Long-term survival and graft function depend largely on effective immunosuppressive therapy. However, clinical practice varies widely across Western, Asian, and resource-limited countries due to differences in epidemiology, donor sources, healthcare infrastructure, and drug availability.
References
1.Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57:675–688.
2.The Japanese Liver Transplantation Society. Liver transplantation in Japan. Available at http://jlts.umin.ac.jp/images/annual/JLTSRegistry2015.pdf. Accessed April 2017.
3.Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2015 Annual Data Report: liver. Am J Transplant. 2017;16(Suppl 1):174–251.
4.Shukla A, Vadeya H, Rela M, et al. Liver transplantation: east versus west. J Clin Exp Hepatol. 2013;3:243–253.
5.de Villa V, Lo CM. Liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007;12:1321–1331.
6.Miller CM, Quintini C, Dhawan A, et al. The International Liver Transplant Society Living Donor Liver Transplant Recipient Guideline. Transplantation. 2017;101:938–944.
7.Park G-L, Gi-Won Song, Deok-Bog M, et al. A review of current status of living donor liver transplantation. Hepatobiliary Surg Nutr. 2016;5:107–117.
8.Grant RC, Sandhu L, Dixon PR, et al. Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transplant. 2013;27:140–147.
9.European Association for the Study of the EASL. Clinical Practice Guidelines: liver transplantation. J Hepatol. 2016;64:433–485.
10.Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010;10:1420–1427.
